Natural Health Trends EBITDA margin
What is the EBITDA margin of Natural Health Trends?
The EBITDA margin of Natural Health Trends Corp. is -4.92%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Consumer Staples sector on NASDAQ compared to Natural Health Trends
What does Natural Health Trends do?
natural health trends corp is an internet company located in 12901 hutton dr, dallas, texas, united states.
Companies with ebitda margin similar to Natural Health Trends
- Melco International Development has EBITDA margin of -4.99%
- Invibes Advertising SA has EBITDA margin of -4.98%
- Kinetix Systems has EBITDA margin of -4.97%
- Adler Modemärkte AG has EBITDA margin of -4.94%
- Ashiana Housing has EBITDA margin of -4.93%
- Timex India has EBITDA margin of -4.92%
- Natural Health Trends has EBITDA margin of -4.92%
- CyberArk Software Ltd has EBITDA margin of -4.91%
- Glory Flame has EBITDA margin of -4.91%
- Bharat Immunologicals & Biologicals has EBITDA margin of -4.90%
- Input Capital has EBITDA margin of -4.90%
- Tz has EBITDA margin of -4.89%
- Docebo has EBITDA margin of -4.89%